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Glomerulonephritis is characterized by hematuria,
proteinuria, hypertension, and edema, but the mechanisms
contributing to volume disorders are controversial. Here we
used the rat anti-Thy1 model of mesangioproliferative
glomerulonephritis to test the hypothesis that disturbed salt
and water homeostasis is based on tubular epithelial changes
that cause salt retention. In this model there was an early
onset of pronounced proteinuria and lipiduria associated
with reduced fractional sodium excretion and a lowering of
the renin–angiotensin–aldosterone system. The glomerular
filtration rate and creatinine clearance were decreased on
day 6. There was a reduced abundance of the major salt and
water transport proteins on the proximal tubular brush
border membrane and which paralleled cellular protein
overload, enhanced membrane cholesterol uptake and
cytoskeletal changes. Alterations in thick ascending limb
were moderate. Changes in the collecting ducts were
characterized by an enhanced abundance and increased
subunit cleavage of the epithelial sodium channel, both
events consistent with increased sodium reabsorption. We
suggest that irrespective of the proximal tubular changes,
altered collecting duct sodium reabsorption may be crucial
for volume retention in acute glomerulonephritis. We
suggest that enhanced proteolytic cleavage of ion
transporter subunits might be a novel mechanism of channel
activation in glomerular diseases. Whether these proteases
are filtered or locally secreted awaits determination.
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Proteinuria is a common feature of acute and chronic
nephropathies and a key predictor of declining glomerular
filtration rate (GFR) in patients. Irrespective of the cause,
proteinuria has been viewed as an independent factor for
tubulointerstitial damage induced by direct toxicity of filtered
protein,1,2 although this concept has been questioned by
others.3–5 As a relevant systemic aspect, the substantial amounts
of protein passing through the damaged filter to be lost in the
urine cause symptoms such as interstitial edema, renal salt and
water retention, and hypertension.6,7 The potential causes for
these disorders have been partly elucidated in models of the
nephrotic syndrome (NS), but few studies have so far addressed
their pathophysiological origins in glomerulonephritis (GN)
and consequent nephritic syndrome.
Salt retention in the NS has traditionally been explained
by the hypovolemia concept, implying decreased oncotic
pressure following proteinuria, loss of fluid into the
interstitium, and activation of the renin–angiotensin–aldos-
terone system.8,9 Meanwhile it has been claimed that the
vascular volume in NS often remains unchanged along with
the absence of blood pressure and renin–angiotensin–aldos-
terone system effects.10,11 It has become accepted that
primary tubular salt retention may per se produce a
substantial systemic volume expansion in proteinuric ne-
phrosis (‘circulatory overfilling’).6,12
Potential sites of sodium retention along the renal tubule
have mostly been studied in the puromycin aminonucleoside
rat model of NS, mimicking minimal change glomerular
disease in human pathology.7,9,13 Retention has been
attributed to changes in the Naþ /Hþ exchanger-3 (NHE3)
as the main pathway for Na reabsorption in the proximal
tubule.13–15 Generally, protein overload may impair proximal
tubule structure and consequent handling of membrane
proteins. Cytoskeletal changes may interfere with trafficking
of transporters and channels, and the effects of inflammatory
and profibrotic cytokines have been implicated.1–3,16–20
Epithelial function may further be hampered by filtered
lipoproteins and tubular accumulation of cholesterol.21,22
Variations in plasma membrane cholesterol content may
therefore alter cell signaling events and influence the viability
of proximal ion transporters.23,24 In the distal nephron,
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regulation of the Naþ -Kþ -2Cl cotransporter-2 (NKCC2)
of thick ascending limb (TAL) of Henle’s loop may be
affected,9 and accumulating evidence points to the collecting
ducts as a crucial site of sodium retention.25,26 Recent study
has been focussed on the activation of the epithelial Naþ
channel (ENaC) in a renin–angiotensin–aldosterone system-
independent way.10,11,27,28 New perspectives have come from
observations that ENaC subunits were cleaved by serine
proteases, increasing the open probability of the channel.29–31
In human disease, NS and acute GN or the resulting
nephritic syndrome may produce in part similar volume
disorders, but clinical features such as hematuria, reduced
GFR, hypertension, and a less pronounced proteinuria are
characteristics of acute GN. The aim of this study was to
analyze tubular causes for volume disorders in the anti-Thy1
rat model for immune-mediated acute GN.
RESULTS
Laboratory parameters and renal functional data
Generally, control rats and anti-Thy1 GN rats were observed
during a 6-day period. As detailed in the ‘Materials and
Methods’ section, three protocols were established to obtain
laboratory parameters during the time course and at the final
time point when kidneys were removed for analysis. On day
6, all anti-Thy1-treated rats had developed severe GN with
marked proteinuria, whereas no changes were recorded in
plasma protein and albumin levels, and signs of ascites were
absent. Urinary protein excretion was markedly enhanced in
anti-Thy1 GN, and so was albumin excretion (protocol (I);
Table 1). Plasma creatinine levels were increased, whereas its
renal clearance was decreased in anti-Thy1 GN rats at the
final time point. Importantly, the 24-h urinary sodium
excretion as well as the urinary sodium/creatinine was
decreased. The fractional excretion of sodium (FENa) was
not significantly altered owing to the decreased GFR. Urinary
osmolality was significantly reduced, which may indicate a
defect in urinary concentrating mechanism but may also be
related to the overall decreased excretion of osmotically active
molecules. Plasma cholesterol and triglyceride levels were
significantly increased (Po0.05) along with much higher
augmentations in urinary free cholesterol and cholesterol
metabolite excretion, indicating hyperlipidemia and excessive
lipiduria (Po0.001; Table 1). The kidney weight was
increased in anti-Thy1 GN rats, suggesting a correlation
with the known disease-related hypertrophy and/or hyper-
plasia of glomeruli and nephron epithelia.
Daily sodium intake and fecal sodium output did not
differ between controls and anti-Thy1 GN rats evaluated
according to protocol (II). In anti-Thy1 GN, daily urinary
sodium output was significantly decreased from day 4
onward and remained low until the end of the experiment
(Figure 1). Daily sodium balance was significantly increased
from day 4 onward and remained positive until the last day.
Proteinuria was maximally elevated on day 2 and remained
high further on. To examine GFR during the time course of
the experiment, inulin clearance was determined in controls
and anti-Thy1 GN rats according to protocol (III) on days 2,
3, 4, and 6. Creatinine clearance and FENa were measured in
parallel (Figure 1). Inulin clearance as well as 24-h creatinine
clearance was not significantly different between anti-Thy1
GN and controls on days 2, 3, and 4, respectively, whereas on
day 6, inulin and creatinine clearances were significantly
reduced. FENa of anti-Thy1 GN rats was significantly reduced
on days 2, 3, and 4, but had increased to control levels on day 6.
Histopathology
Immunohistochemical staining for the C5b-9 membrane
attack complex indicated complement deposition in the
mesangium in anti-Thy1 GN compared with control (Figure
2a and b). Paraffin histology revealed glomerular hypertro-
phy, mesangiolysis, and formation of proteinaceous crescents
within Bowman’s space. Tubules focally displayed not only
collapse or atrophy and cast formation, but also epithelial
hypertrophy (Figure 2c and d). Periodic acid Schiff-positive
deposits were detected in proximal tubule and medullary and
Table 1 | Clinical parameters and alterations in renal function
Controls Anti-Thy1 GN
General data
Body weight (g) 264.88±10.77 258.68±17.10
Kidney weight (g) 2.19±0.17 2.85±0.55*
Mean systolic blood pressure
(mm Hg)
122.33±3.10 122.32±3.96
Water uptake (ml) 34.60±10.69 36.90±14.08
Urinary volume (ml) 17.19±4.17 20.01±13.25
Plasma analysis
Na+ (mmol/l) 152.20±0.42 153.20±0.38
K+ (mmol/l) 5.22±0.42 4.32±0.38
Cl (mmol/l) 101.60±2.61 105.40±5.59
Protein (g per 100 ml) 4.96±0.40 4.60±0.28
Albumin (g per 100 ml) 2.42±0.64 2.40±0.48
Creatinine (mg per 100 ml) 0.20±0.05 0.35±0.08*
Cholesterol (mg per 100 ml) 51.36±10.51 82.50±22.47*
Triglyceride (mg per 100 ml) 68.91±24.97 135.75±76.15*
Urea (mg per 100 ml) 31.60±10.55 75.00±15.70*
Renal function
Creatinine-clearance GFR
(ml/min per g body weight)
11.93±2.89 6.88±1.33*
Fractional Na+ excretion (FENa;%) 0.34±0.12 0.37±0.14
Urinary analysis
Na+ (mmol per 24 h) 2.16±0.14 1.58±0.23*
K+ (mmol per 24 h) 4.94±0.67 3.36±0.22*
Cl (mmol per 24 h) 2.91±0.22 2.04±0.21*
Osmolality (mOsm per kg H2O) 1640±100 1040±180*
Protein (mg per 24 h) 15.07±5.86 156.13±64.11w
Albumin (mg per 24 h) 0.19±0.23 23.02±6.45w
Creatinine (mg per 24 h) 9.47±0.93 8.64±1.00
Urea (mg per 24 h) 673.18±136.64 490.55±53.73
Free cholesterol (mg per 24 h) 7.53±4.46 115.95±49.11w
Cholesterol linoleate
(mg per 24 h)
2.28±2.28 393.15±143.56w
Cholesterol arachidonate
(mg per 24 h)
8.15±6.42 1452.65±788.87w
GFR, glomerular filtration rate; GN, glomerulonephritis.
Values are measured on the last day of the experiment (protocol I; day 6;
means±s.e.).
*Po0.05; wPo0.005; n=10.
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cortical TALs. Massive accumulations of lysosomes were
identified in the proximal tubule (Figure 2e and f).
Occasionally, loss of brush border membrane (BBM) was
observed, and the abundances of villin as a major BBM
component, and megalin, a protein involved in endocytosis,
were reduced in anti-Thy1 GN (Figure 3a).
Expression of cortical and medullary transporter and channel
proteins
Differential abundance of the major ion and water transpor-
ters and channels along the nephron and collecting duct
system was evaluated by western blot. Proximal tubular
aquaporin-1 (AQP1), NHE3, and Naþ -Pi cotransporter-IIa
(NaPi-IIa) were quantified from BBM preparations. Densito-
metric evaluation of band intensities revealed reduced
expression of these transporters in anti-Thy1-treated animals
(Figures 3 and 4; Table 2). These data were confirmed by
immunohistochemical staining showing reduced intensity of
AQP1, NHE3, and NaPi-IIa in the BBM of anti-Thy1 GN rats
(Figure 5). The abundances of AQP2, NHE3, NKCC2, Naþ -
Cl cotransporter (NCC), aENaC, bENaC, gENaC, aNa-
,Kþ -ATPase (aNKA), and bNKA were evaluated by western
blots from cortical membrane fractions. Densitometric
quantification revealed a significant upregulation of aNKA,
aENaC, and gENaC expression (Figures 3 and 4; Table 2). For
aENaC and gENaC, apart from the major mature bands at
approximately 90 kDa, additional lower molecular weight
bands were present at approximately 65 and 70 kDa,
respectively, and for gENaC, a second additional band at
55 kDa was registered (Figure 3). These additional bands were
a b
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Figure 2 | Histopathology of anti-Thy1 GN. (a and b) Indirect
immunofluorescence staining of C5b-9 membrane attack
complex. Deposits of C5b-9 are visible in extra- and
intraglomerular mesangium and occasionally at the
juxtaglomerular apparatus in GN (b). (c and d) Periodic acid Schiff
staining of kidney sections from control (c) and GN (d). Severe
glomerular and mild tubulointerstitial changes are obvious in GN
(d). (e and f) Fine structural evaluation of proximal tubule cells
from control (e) and GN (f). A strong accumulation of secondary
and tertiary lysosomes is observed in GN (e). (a–d) Magnification
 250; (e and f) magnification  4600. GN, glomerulonephritis.
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Figure 1 | Daily sodium metabolism, proteinuria, and renal
function in anti-Thy1 GN. Rats had either received vehicle
(control) or OX-7 for induction of anti-Thy1 GN. Days are numbered
from 24 h after the injection onward. Panels show sodium handling,
proteinuria, GFR, and FENa as obtained from collections in metabolic
cages, blood sampling, and clearance measurements. Daily sodium
intake and fecal sodium output show no differences between
groups. Daily urinary sodium output in anti-Thy1 GN rats diverges
from controls from day 4 onward, with parallel increases in sodium
balance. Proteinuria in anti-Thy1 GN is raised from day 2 onward and
remains strong throughout the experiment. GFR, as obtained by 24 h
creatinine clearance and by inulin clearance, differs between groups
on day 6. FENa is significantly decreased on days 2 and 4, but equals
control levels on day 6. Panels a–e are from protocol (II) (n¼ 12), and
f–h from protocol (III) (n¼ 10 on each time point); values are
means±s.e.; *Po0.05. GFR, glomerular filtration rate; GN,
glomerulonephritis.
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strongly increased in anti-Thy1 GN, suggesting a selective
cleavage of ENaC subunits under the proteinuric condition.
The mature ENaC subunits in the 90 kDa range typically
appeared as double bands, possibly owing to different
glycosylation levels; they did not dissociate in GN and were
therefore evaluated together. In contrast, abundances of
AQP2, NHE3, NKCC2, NCC, bENaC, and bNKA were not
significantly altered in anti-Thy1 GN (Figures 3 and 4;
Table 2). Immunostaining for aNKA showed significant
increases in basolateral staining along the entire cortical
nephron and collecting duct system (Figure 6a and b). Signals
for aENaC and gENaC showed an apical shift of signals in
connecting tubule and collecting duct principal cells (Figure
6c–f). Medullary membrane preparations revealed analogous
changes as found in the cortex, with aNKA, aENaC, and
gENaC expression significantly increased as determined by
western blotting and densitometric evaluation; increases in
Control
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Figure 3 | Semiquantitative immunoblotting of transporter
and channel proteins along the nephron. (a) Abundance of
aquaporin-1 (AQP1), Naþ /Hþ exchanger-3 (NHE3), Naþ -Pi
cotransporter-IIa (NaPi-IIa), megalin, and villin from brush border
membrane fractions. (b) Abundance of a-subunit of Naþ ,Kþ -
ATPase (NKA), and a- and g-subunits of the epithelial Naþ -
channel (ENaC) from cortical membrane fractions. (c) Abundance
of aNKA and a- and gENaC from medullary membrane fractions.
Apart from the major 90 kDa bands, additional lower molecular
weight bands indicate increases in the cleaved forms of ENaC
subunits in GN (b and c). The respective densitometric
calculations are given in Table 2. GN, glomerulonephritis.
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Figure 4 | Abundance of transporters and water channels
along the nephron. A summary of densitometric values from
immunoblots shown in Figure 3: aquaporin-1 (AQP1), Naþ /Hþ
exchanger-3 (NHE3), Naþ -Pi cotransporter-IIa (NaPi-IIa),
aquaporin-2 (AQP2), bumetanide-sensitive Naþ -Kþ -2Cl
cotransporter-2 (NKCC2), thiazide-sensitive Naþ -Cl cotransporter
(NCC), a-, b-, and g-subunits of epithelial Naþ channel (ENaC), and
a- and b-subunits of Naþ ,Kþ -ATPase (NKA) from anti-Thy1 GN
shown as percent deviations from controls, normalized to b-actin;
brush border membrane fractions (dark gray columns), cortical
membrane fractions (black columns), and medullary membrane
fractions (gray columns). Values are means±s.e.; n¼ 10; *Po0.05.
GN, glomerulonephritis.
Table 2 | Western blot results of full-length and cleavage
products of epithelial Na+ channel a- and c-subunit on days
2, 4, and 6
Cortical PM fraction, day 6
aENaC (90 kDa) 35.37±09.05 vs 100±12.77
aENaC (65 kDa) 251.88±36.84 vs 100±13.12*
gENaC (90 kDa) 154.85±27.22 vs 100±16.28
gENaC (70 kDa) 220.90±15.24 vs 100±05.72*
gENaC (55 kDa) 139.14±11.26 vs 100±02.02*
Medullary PM fraction, day 6
aENaC (90 kDa) 132.30±03.11 vs 100±03.78*
aENaC (65 kDa) 305.04±37.19 vs 100±11.49*
gENaC (90 kDa) 199.40±25.70 vs 100±09.79*
gENaC (70 kDa) 293.31±28.76 vs 100±07.93*
gENaC (55 kDa) 124.16±13.71 vs 100±02.02
Abbreviation: ENaC, epithelial Na+ channel.
Values are densitometric intensity levels normalized for b-actin (means±s.e.).
*Po0.05; n=5 per group.
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aENaC and gENaC abundance were higher than in the cortex
and also included the selective enhancements of the
additional lower molecular weight bands in anti-Thy1 GN
(Figures 3 and 4; Table 2). Immunostaining for outer
medullary aNKA showed significant increases in basolateral
staining along the proximal tubules and, more intensely, in
collecting ducts (Figure 6g and h). Inner medullary collecting
ducts showed enhanced aNKA staining in anti-Thy1 GN as
well. As in cortex, signals for aENaC and gENaC showed
apical signal increases in the collecting ducts (Figure 6i–l).
During the time course of the experiments, increases in
aNKA and selectively in the smaller aENaC and gENaC
bands were also registered in whole kidney plasma membrane
preparations from anti-Thy1 GN rats on days 2 and 4
(protocol (III); Table S1, Figure S1).
Anti-Thy1 GN-induced changes in renin, vasopressin, and
11bHSD-2
To assess whether changes in renal endocrine function could
be related to alterations in epithelial transport under anti-
Thy1 GN on day 6, we analyzed renal renin expression and
plasma renin activity (PRA), plasma vasopressin, and the
expression of 11b-hydroxysteroid dehydrogenase type-2
(11bHSD-2) as an essential tubular parameter mirroring
the action of corticosteroids. Renal renin mRNA and protein
Anti-Thy1 GNControl
AQP1
NHE3
NaPi-IIa NaPi-IIa
NHE3
AQP1
Figure 5 | Immunohistochemical staining of altered proximal
tubular transport proteins: controls (left panels) and anti-
Thy1 GN (right panels). (a and b) proximal tubular aquaporin-1
(AQP1); (c and d) proximal tubular Naþ /Hþ exchanger-3 (NHE3);
(e and f) proximal tubular Naþ -Pi cotransporter-IIa (NaPi-IIa).
Expression of AQP1, NHE3, and NaPi-IIa is strongly reduced in anti-
Thy1 GN. (a–d) Magnification  200; (e and f) magnification
 150. GN, glomerulonephritis.
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Figure 6 | Immunohistochemical staining of altered distal
tubular transport proteins: controls (left panels) and anti-
Thy1 GN (right panels). (a and b) a-subunit of Naþ ,Kþ -ATPase
(aNKA), cortex with proximal segments (asterisk), and distal
tubules (#); (c and d) a-subunit of the epithelial Naþ channel
(aENaC) in connecting tubule; (e and f) g-subunit of ENaC (gENaC)
in connecting tubule; (g and h) aNKA, outer medulla, with
proximal segments (asterisk) and collecting ducts (1); (i and j)
aENaC in outer medullary collecting ducts; (k and l) gENaC in
outer medullary collecting ducts. The abundance of aNKA is
enhanced throughout, whereas ENaC signals are shifted toward
the apical membrane in GN. (a, b, g, h) Magnification  150; (c–f
and i–l) magnification  400. GN, glomerulonephritis.
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signals were significantly reduced in anti-Thy1 GN-treated
rats compared with controls (0.56±0.09 vs 1.00±0.09 for
renin mRNA and 0.50±0.03 vs 1.00±0.13 for renin
immunoreactivity; Po0.05; protocol (II); Figure 7). These
results were paralleled by reduced PRA (0.53±0.10 vs
1.00±0.16; Po0.05; protocol (II); Figure 7e). Plasma
vasopressin levels in anti-Thy1 GN were not different from
those in controls (22.80 vs 24.85 pg/ml). Likewise, the
abundance of 11bHSD-2 expression as estimated by Western
blots was not significantly altered on day 6 (1.05±0.09 vs
1.00±0.15 in the cortex and 1.01±0.11 vs 1.00±0.17 in the
medulla). To assess the time course of PRA, plasma was
sampled on days 2, 3, 4, and 6 (protocol (III)). Here, PRA in
anti-Thy1 GN was numerically reduced on days 2, 3, and 4,
but reached significance only on day 6 (Figure 7f).
Lipid composition of fractionated cell membranes
Effects of lipiduria (Table 1) on the absolute and esterified
cholesterol content of BBM and medullary membrane
fractions were studied by high-performance liquid chroma-
tography. In both fractions, free cholesterol was augmented
in the anti-Thy1 GN group compared with controls
(0.63±0.13 vs 0.36±0.11 and 0.41±0.02 vs 0.33±0.03 mg
per mg protein, respectively; Po0.05; Figure 8a and b). In
medullary membrane fractions, the abundance of esterified
cholesterol showed particularly strong changes between
groups.
Analysis of intracellular lipid accumulation
Intracellular lipid deposition was markedly increased in
proximal tubule and TAL as revealed histochemically by the
general lipid-staining agent, Sudan III (Figure 9b and d),
whereas no signal was observed in control kidneys (Figure 9a
and c). More specifically, intracellular cholesterol was
identified by filipin staining, with signals localized to the
cell membranes of epithelia in both groups (Figure 9e–h).
Signal was enhanced in BBM and apical TAL cell membranes
from anti-Thy1 GN kidneys (Figure 9f and h), and
intracellular cholesterol deposits were identified in proximal
and distal epithelia (Figure 9i and j).
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Figure 7 | Renin measurements. (a–d) representative images of
histochemical abundances at the juxtaglomerular apparatus for
renal renin mRNA (a and b) and renal immunoreactive renin (c
and d) in controls (left panels) and anti-Thy1 GN (right panels) on
day 6. Signals are reduced in GN. (e) Quantification of renal renin
mRNA, renal immunoreactive renin, and plasma renin activity
(PRA) on day 6. (f) Time course of PRA obtained on days 2, 3, 4,
and 6. PRA in GN diverges significantly from controls on day 6.
(a–e) From protocol (I) (n¼ 10); (f) is from protocol (III) (n¼ 10 on
each time point). (a–d) Magnification  400; values are
means±s.e.; *Po0.05. GN, glomerulonephritis.
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Figure 8 | Alterations in membrane lipid composition as
obtained from HPLC analysis. Lipids had been extracted from
membrane fractions. (a and b) Free cholesterol and esterified
cholesterol (cholesterol linoleate and cholesterol arachidonate) in
brush border membrane (BBM) (a) and medullary membrane
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glomerulonephritis; HPLC, high-performance liquid
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Alterations in microtubule arrangements
Microtubules showed reduced a-tubulin immunostaining
in proximal tubules of anti-Thy1 GN kidneys (Figure 10a
and b). Microtubules of TAL were irregularly distributed and
accumulated near the apical plasma membrane (Figure 10c
and d).
DISCUSSION
This study contributes to the discussion whether primary,
intrarenal-based salt and water retention or other systemic
causes prevail in the volume disorders accompanying acute
GN or the nephritic syndrome. To our knowledge, this study
so far is the first approach to investigate mechanisms for
primary sodium retention in immune-mediated GN. There
is, however, overlap between our data and data on NS, which
renders the present conclusions more broadly applicable
among the two major glomerular syndromes. We have
confirmed the known pathological and clinical landmarks of
anti-Thy1 mesangioproliferative GN with glomerular C5b-9
accumulation, marked proteinuria and albuminuria, and
reduced creatinine clearance.4,19,32,33 In contrast to human
GN, which can be associated with hypertension, anti-Thy1
GN in this study produced no changes in blood pressure. We
could, however, present clear evidence for sodium retention
as revealed by the markedly reduced absolute sodium
excretion and reduced FeNa, suggesting a tendency toward
increased systemic blood pressure, which may become more
obvious with progression;34 it was not until the final time
point on day 6 that the difference in FeNa was blunted owing
to a marked fall in GFR. Reduced renin angiotensin system
parameters further agree with earlier data in anti-Thy1 GN.35
Our study has revealed a number of segmental tubular
epithelial changes, which together suggest that intrarenal
a b
c d
Figure 10 | Alterations of the cytoskeleton. (a–d) Triple staining
of a-tubulin (green), f-actin (red), and nuclear staining with DAPI
(blue) in proximal tubule (a and b) and medullary thick ascending
limb profiles (TAL; c and d). Microtubules show diminished
staining and reorientation in proximal epithelia of anti-Thy1 GN
rats (b) compared with controls (a), and apical accumulation in
patches, indicated by arrows, within TAL of anti-Thy1 GN (d)
compared with controls (c). (a and b) Magnification  400; (c and
d) magnification  600. DAPI, 40,6-diamino-2-phenylindole; GN,
glomerulonephritis; TAL, thick ascending limb.
a b
c d
e f
g h
i j
Figure 9 | Cellular lipid accumulation shown by histochemical
lipid labeling in controls (left panels) and anti-Thy1 GN (right
panels). (a–d) Sudan III general lipid staining; intracellular
deposition of lipid droplets was restricted to proximal tubules (b)
and medullary thick ascending limbs (TAL; d) of anti-Thy1 GN rats.
(e–j) Fluorescent filipin staining of free cholesterol. In the cortex of
controls, staining in brush border membrane of proximal tubules
(arrowheads; e and f) and apical membrane of distal tubules
(arrowheads; g and h) is enhanced in anti-Thy1 GN. Cholesterol
droplets are occasionally observed focally in proximal tubules (#; i)
and TAL (asterisk; j) of anti-Thy GN rats. (a–j) Magnification  400.
GN, glomerulonephritis.
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rather than systemic or circulatory factors may be involved in
GN-related volume disorders.
With the bulk of sodium reabsorption occurring in the
proximal tubule, this segment was considered to contribute
to volume retention as reported from nephrotic rats.13
However, the substantial reduction in BBM expression
of three major proximal transport proteins in GN is
opposed to enhanced sodium reabsorption at this site.
Reduction of NHE3 as the principal representative of sodium
entry reflects other similar findings in nephrotic rats;27 along
the same line, a micropuncture study in rats with unilateral
nephrosis25 showed reduced sodium reabsorption in prox-
imal convoluted tubule and TAL. The reduced renin levels in
anti-Thy1 GN, along with possibly reduced circulating
angiotensin II levels, may as well be associated with retraction
of NHE3 from the BBM and reduced sodium transport
activity.15,36
The decrease in GFR in the anti-Thy1 GN group on day 6
suggests activation of tubulo-glomerular feedback. The
drastic decrease in BBM AQP1 expression confirms this
view, as AQP1-deficient mice losing up to 89% of proximal
transcellular water passage had an activated feedback that
prevented inadequate water and NaCl delivery to the distal
nephron.37,38 In keeping with this, the stabilization of sodium
and water delivery to the postmacula region in NS was
accomplished through an activated feedback.25,26
Patients with NS have multiple abnormalities in lipid
metabolism, and fatty acids bound to albumin pass through
the filter to reach the renal tubule in this condition.21,39 Our
results have shown an accumulation of cholesterol and its
metabolites in proximal tubule BBM and medullary mem-
branes along with the histochemical evidence for intracellular
and membrane lipid accumulation. An excess of cellular fatty
acids may cause cell dysfunction, and mice loaded with fatty
acid and bovine serum albumin exhibited systemic water
retention40 so that altered transepithelial reabsorption of
sodium and water in the present model may be related with
these changes. As NaPi-IIa, NHE3, and possibly also AQP1
are lipid raft associated, trafficking or membrane association
of these proteins may be impaired in an altered cholesterol
environment.23,24,41,42 This may as well be applied for distal
epithelia in which NKA,43 NKCC2,44 and ENaC45 were shown
to be partially lipid raft dependent. The effects of lipid
accumulation in the proximal tubule as compared with TAL
may, however, be distinct with respect to activity of their
membrane transporters. Accordingly, susceptibility to lipid
accumulation of the proximal BBM and elaborate endosomal
and recycling structures, and sites of complex shuttling routes
to and from a transporter’s site of action may not be the same
as in the comparatively simple structures of the apical cell
aspect in TAL. This may cause diverging effects regarding
surface expression of the respective transporters.
Proteinuria has been classified as an independent risk
factor in tubulo-interstitial disease, and much attention has
been directed to inflammatory cytokines such as transform-
ing growth factor-b in profibrotic signaling in response to
protein overload.1–3,19,20 Evidence thus points to transform-
ing growth factor-b among the candidate products to
determine proteinuria-related perturbation of the proximal
tubule cells with regard to their apical transporters. The
induction of transforming growth factor-b requires megalin/
cubilin-dependent albumin uptake during protein overload,
which has been demonstrated in megalin-deficient mouse
models.3 Among the consequences, major reductions in
NHE3 activity and AQP1 abundance in another nephritic
mouse model have been demonstrated.46 Drastic cytoskeletal
rearrangements have been shown earlier in proximal tubule
cells exposed to transforming growth factor-b1, and their
assumption of a fibroblastic nature was interpreted as
epithelial–mesenchymal transition.20,47 This and other stu-
dies, however, have provided little or no evidence for
epithelial–mesenchymal transition.3,5 The observed micro-
tubular fragmentation rather agrees with the decreased
surface expression of the transporters and thus with their
diminished activity.16,17,48 Microtubular changes were found
also in TAL, but their adluminal appearance as well as the
Western blot data on NKCC2 abundance was quite variable
in our model, which agrees with the absence of clear changes
in plasma vasopressin levels. Data on NKCC2 abundance in
NS have been controversial as well.49,50
We have shown substantially enhanced expression of the
a- and g-subunits of ENaC, which is in keeping with our
earlier study stating that the crucial site of sodium retention
in proteinuric nephropathy lies beyond the distal convoluted
tubule.9,25–27 Amiloride, a diuretic that blocks ENaC-
mediated sodium uptake, was consequently effective to
restore sodium balance in cortical collecting duct (CCD)
from kidneys with NS in an aldosterone-independent
manner,7,10,28 which agrees with the present lack of changes
in 11bHSD-2, an enzyme mirroring the action of corticos-
teroids and their possible effects on NKA.10,51,52 The rate-
limiting role of ENaC has, however, also been questioned by
some, stating that primary, aldosterone-independent induc-
tion of NKA may represent a sufficient mechanism for salt
retention at the CCD in NS.10,14 Conversely, increases in the
abundance or shifts in the electrophoretic patterns of ENaC
subunits may as well be viewed from the point that a related
rise in intracellular sodium concentration per se can raise the
activity of NKA.53
In this respect, the selective enhancements of the smaller
65 kDa band for the a-subunit and approximately 70 and
55 kDa bands for the g-subunit in anti-Thy1 GN suggest that
these electrophoretic shifts were related to enzymatic cleavage
of the subunits, which partly would agree with published
evidence on the size of cleaved ENaC products.30,31,54,55 It has
been well established that cleavage of ENaC subunits by
proteases may lead to an activation of the channel. This
mechanism has been illustrated by the original observation
that amiloride-sensitive sodium currents had increased in
response to extracellular serine protease,54 and exogenously
added trypsin or elastase as well as resident channel-
activating proteases were later shown to have similar
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effects.29,31,55 Along the same line, proteases obtained from
urines of nephrotic rats, such as the serine protease plasmin,
were shown to activate ENaC.30
The origin of the 65 kDa aENaC band is not clear, as
available data suggest that this molecular weight level is the
result of endogenous cleavage.55 Selective upregulation of the
approximately 70 kDa-sized gENaC band, however, may well
agree with published data on exogenous proteases generating
a 67 kDa product.55,56 The 55 kDa gENaC band has been
mentioned earlier in the context of glycosylation so that it is
unclear whether its selective increase in the medullary
membrane fractions in the context of proteinuria is caused
by proteolytic cleavage or deglycosylation, and whether this is
related to an altered channel activity.57 Together, ENaC
cleavage products were elevated from early on during the
time course of the study; already the initial increase in
proteinuria on day 2 was accompanied by the selective rise in
cleavage products along with elevated NKA abundance and
reduced FENa; their causal links, however, remain to be
established in future studies.
In sum, our study has identified renal changes in anti-
Thy1 GN, which may be relevant to volume retention,
hypertension, and edema formation in human nephritic
syndrome. Our model shares some similarities with data
obtained from nephrotic animal and cell models suggesting
that altered filtrate composition and its tubular handling are
the common denominators in renal-based phenotypic
changes and antinatriuresis. In spite of marked alterations
in proximal tubular BBM transporters, likely to be caused by
the protein and lipid overload, our data support the notion
that volume retention in acute GN, similar to NS, is focussed
on sodium transport in the collecting ducts. Results are
consistent with an otherwise established concept that
proteolytic cleavage may activate ENaC subunits. Filtered
plasma proteases could thereby facilitate apical sodium entry
and cause volume retention in glomerular proteinuric
syndromes.
MATERIALS AND METHODS
Animals and experimental protocol
Male Wistar rats (n¼ 116) weighing between 180 and 200 g were
obtained from Charles River (Sulzfeld, Germany). Anti-Thy1 GN
was induced by an intravenous injection of monoclonal antibody to
OX-7 (1 mg per kg body weight in phosphate-buffered saline (PBS);
pH 7.5) or vehicle (PBS).19 Three sets of experiments (protocols
I–III) were performed. Protocol (I): controls and anti-Thy1 GN rats
(total n¼ 24) were used for the evaluation of histochemical,
biochemical, and standard clinical parameters; rats were kept in
normal cages during 6 days after the injections. They had
unrestricted access to standard laboratory chow and tap water. For
urine collection, rats were placed in metabolic cages during the last
24 h of the experiment. On day 6, 12 rats were isoflurane
anesthetized, blood was collected, and the kidneys removed for
biochemical analysis; the other 12 rats were perfusion fixed. Protocol
(II): to determine salt balance on a daily base, controls and
anti-Thy1 GN rats (total n¼ 12) were kept in metabolic cages
throughout the experiment starting 24 h before injection of anti-
Thy1 antibody. On day 6, blood samples were obtained and the
animals killed. Protocol (III): to determine GFR by inulin
clearance, controls and anti-Thy1 GN rats (total n¼ 80) were
analyzed on days 2, 3, 4, and 6 after the injections. Clinical
parameters including PRA were determined in parallel. Kidneys were
obtained on days 2 and 4 for additional biochemical analysis (total
n¼ 20). Rats were pair fed in protocols (II) and (III). All
experiments were conducted in accordance with the German law
for the protection of animals (project accredited by Berlin Senate
Administration of Health).
Urine, blood, food, and fecal analysis
Serum and urine electrolytes were determined by indirect ion-
selective electrode measurements (Modular Analytics; Roche
Diagnostics, Mannheim, Germany). Urine osmolality was measured
with an osmometer (Gonotec, Berlin, Germany). Blood urea
nitrogen was quantified enzymatically and serum creatinine
concentration was measured by the kinetic Jaffe´ method using
routine automated methods (Modular Analytics; Roche Diagnostics).
Creatinine clearance and fractional sodium excretion were calculated
using standard equations. Total protein and albumin concentrations
in serum and urine as well as cholesterol and triglyceride levels in
serum were measured using standardized autoanalyzer methods
(Hitachi 747, Hitachi 911, and STA analyzers; kits from Roche
Diagnostics). Urinary concentration of free cholesterol and choles-
terol esters was determined from total urinary lipid extracts by high-
performance liquid chromatography (Shimadzu SPD-M10AVP
instrument). Cholesteryl benzoate and/or cholesteryl pelargonate
were used as external standards. For sodium measurements from
feces and food, these were dried at 105 1C until a constant weight
was reached, dissolved in 0.7 mol/l HNO3, homogenized, and placed
on a shaking table. Finally, sodium concentrations were determined
in the supernatant by flame photometry (AFM 5051; Eppendorf,
Hamburg, Germany).
Inulin clearance measurements
To determine inulin clearance, rats were anesthetized with
isoflurane. Femoral veins and ureters were cannulated with
polyethylene catheters. After receiving 10 ml per kg body weight of
0.45% saline to replace fluid losses during surgery, rats were given a
bolus of 1% inulin/PBS intravenously, followed by a 90-min
infusion period of 1% inulin/PBS (0.9 ml/h) and a 2-h infusion
period of 1% inulin/0.45% saline as described.58 Blood was collected
during the ensuing 30-min clearance period for the determination
of inulin concentration. Urine and plasma concentrations of inulin
were determined by a kit (D-Glucose/D-Fructose Kit; R-Biopharm
AG, Darmstadt, Germany).
Perfusion fixation and tissue processing for
immunohistochemical evaluation
Rats were anesthetized by an intraperitoneal injection of
sodium pentobarbital (0.06 mg per g body weight). Kidneys were
then perfused in vivo through the abdominal aorta using 3%
Paraformaldehyde (PFA) dissolved in PBS. For cryostat sectioning,
tissues were protected from freezing artifacts by 800 mOsm sucrose/
PBS, shock-frozen in cooled isopropane, and stored at 801C.
Alternatively, tissues were post-fixed in 3% PFA/PBS, dehydrated,
and standard paraffin embedded. For ultrastructural analysis, kidney
specimens were post-fixed in 1.5% PFA/PBS containing 1.5%
glutaraldehyde and 0.05% picric acid, rinsed, and stored in PBS
until embedding in Epon (Serva, Heidelberg, Germany).
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Tissue processing for immunoblotting
Fractionation of the proximal tubule BBM of kidney cortices was
performed as described.59 Enrichment of BBM was found to be
unaffected by the anti-Thy1 treatment based on the fact that the
ratios between BBM and total cortical homogenate in alkaline
phosphatase and g-glutamyltransferase activities in controls and
anti-Thy1-GN rats were not different ( 5.7±0.6 vs  7.8±4.8 and
 6.4±1.4 vs  7.6±1.8, respectively; n.s.). Preparations of cortical
and medullary membrane fractions were performed as described.60
Total protein concentration was measured using a protein assay
reagent kit (BCA; Pierce, Rockford, IL, USA).
Electrophoresis and SDS-polyacrylamide gel electrophoresis
SDS gel electrophoresis was performed on 6–10% gradient
polyacrylamide gels. To confirm equal loading of protein, an initial
gel was stained with Coomassie blue. After electrophoresis, the
proteins were transferred to nitrocellulose membranes and stained
with 0.1% Ponceau red. After incubation with blocking reagent,
membranes were probed with primary antibodies and then
exposed to horseradish peroxidase-conjugated secondary antibodies
(DAKO, Hamburg, Germany). Immunoreactive bands were visualized
using an enhanced chemiluminescence kit and exposure to X-ray films
(Amersham Pharmacia, Buckinghamshire, UK). Films were analyzed
using BIO-PROFIL Bio-1D image software (Vilber Lourmat, Ger-
many). Finally, all data were corrected for b-actin expression.
Antibodies
For immunohistochemistry and immunoblotting, we employed
well-characterized antibodies to the following proteins: C5b-9
membrane attack complex (gift from S. Shankland, Washington,
WA, USA); AQP1 (BD Transduction laboratories, San Jose, CA,
USA); NaPi-IIa (gift from J. Biber, Zurich, Switzerland); NHE3
(Biotrend, Cologne, Germany); megalin (raised against a C-terminal
peptide sequence); villin (gift from D. Drenckhahn, Wu¨rzburg,
Germany); b-actin (Sigma Aldrich, Munich, Germany); NKCC2 and
NCC (both gifts from D. Ellison, Portland, OR, USA); a-, b-, and g-
subunits of ENaC (gift from B. Rossier (Lausanne, Switzerland)) and
sera produced against N-terminal GST protein of a-subunit and
C-terminal GST proteins of b- and g-subunits of ENaC; aNKA and
bNKA (Upstate Biotechnology, Lake Placid, NY, USA); AQP2 (Santa
Cruz Biotechnology, Santa Cruz, CA, USA); renin (gift from A.
Kurtz, Regensburg, Germany); a-tubulin (Sigma Aldrich); and
11bHSD-2 (Chemicon, Temecula, NM, USA). For f-actin staining,
Alexa 488-phalloidin (Invitrogen, Carlsbad, CA, USA) was used.
Immunohistochemistry
Immunohistochemical staining was performed on cryostat or
paraffin sections and on cells grown on glass cover slips. Initially,
sections were blocked and incubated with the respective primary
antibody followed by incubation with suitable horseradish perox-
idase (DAKO) or cy-2- or cy-3-coupled secondary antibodies
(Dianova, Hamburg, Germany). In double-labeling experiments,
the primary antibodies were administered consecutively. Nuclei were
stained blue with 40,6-diamino-2-phenylindole. Counterstained
sections and cells were analyzed using Leica DMRB microscope or
multilaser confocal scanning microscope (TCS SP-2; Leica Micro-
systems, Bernsheim, Germany).
Periodic acid Schiff, Sudan III, and filipin staining
For histochemical detection of glycoproteins and lipid classes, 4-mm
thick cryostat or paraffin sections were stained with periodic acid
Schiff reagent or Sudan III. For filipin staining, cryostat
sections were blocked with 0.5% bovine serum albumin or 1%
goat serum in PBS and incubated for 2 h with 0.005% filipin
complex dissolved in dimethyl sulfoxide (Sigma Aldrich). As a
negative control, an equivalent concentration of DMSO alone
was used.
Analysis of membrane lipid composition
To evaluate membrane lipid composition, BBM and medullary
membrane preparations were methanol extracted according to the
Bligh–Dyer method. The absolute amounts of lipids were then
determined by reverse-phase high-performance liquid chromato-
graphy, separating free cholesterol and the major cholesterol esters
(cholesteryl arachidonate, cholesteryl linoleate, cholesterol oleate,
and cholesteryl stearate).61
In situ hybridization
The mRNA expression of renin was explored by in situ hybridization
using digoxigenin-labeled riboprobes (Roche, Grenzach-Wyhlen,
Germany). Sense and antisense probes were generated by in vitro
transcription of 300 bp fragment of the corresponding cDNA. In situ
hybridization was performed on paraffin sections according to an
established protocol.60
Renal and plasma renin contents
To estimate tissue activity of the renin angiotensin system,
histochemical signals were semiquantitatively evaluated. Alterations
in renin transcripts and protein abundance were registered. The
mean number of renin-positive sites at the juxtaglomerular
apparatus and the upstream locations in preglomerular vessels was
determined within an area of approximately 100 glomeruli.62 Both
the amount of renin mRNA and immunoreactive renin-containing
afferent arterioles was quantified. PRA was measured with a
commercial radioimmunoassay kit (Gammacoat; DiaSorin, Still-
water, MN, USA). One microliter of plasma was mixed on ice with
24 ml of maleate buffer containing EDTA, neomycin sulfate, and
phenylmethanesulfonylfluoride. To determine background angio-
tensin I levels, 12 ml of this mix was removed and kept frozen until
assaying. The remaining aliquot was incubated with angiotensino-
gen for 1 h at 371C. Generated angiotensin I was measured by
radioimmunoassay using standards and reagents provided by the
manufacturer. In each assay, angiotensin I levels determined in the
non-incubated plasma aliquot were subtracted (Beckman Multi
Counter, Fullerton, CA, USA).
Plasma vasopressin concentrations
Plasma arg8-vasopressin concentrations were determined by enzyme
immunoassay according to the manufacturer’s protocol (Assay
Designs, Ann Arbor, MI, USA). All assays were run in duplicate.
Recombinant arg8-vasopressin provided by the manufacturer was
used to establish a standard curve for calculation of sample arg8-
vasopressin concentrations. Sample absorption was determined at
405 nm with correction at 570 nm (uQuant; Biotek-Instruments,
Winooski, VT, USA).
Presentation of data and statistical analysis
Quantitative data are presented as means±s.e. For statistical
comparison, the Mann–Whitney rank-sum test was employed.
P-values less than 0.05 were considered statistically significant.
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